MAFLD: A multisystem disease
RM Pipitone, C Ciccioli, G Infantino… - Therapeutic …, 2023 - journals.sagepub.com
Nonalcoholic fatty liver disease (NAFLD), affecting about 25% of general population and
more than 50% of dysmetabolic patients, is an emerging cause of chronic liver disease and …
more than 50% of dysmetabolic patients, is an emerging cause of chronic liver disease and …
Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?
Non-alcoholic fatty liver disease (NAFLD) has become one of the most common forms of
chronic liver disease worldwide and its prevalence is expected to continue rising. NAFLD …
chronic liver disease worldwide and its prevalence is expected to continue rising. NAFLD …
SGLT-2 inhibitors in NAFLD: expanding their role beyond diabetes and cardioprotection
Non-alcoholic fatty liver disease (NAFLD) is an 'umbrella'term, comprising a spectrum
ranging from benign, liver steatosis to non-alcoholic steatohepatitis, liver fibrosis and …
ranging from benign, liver steatosis to non-alcoholic steatohepatitis, liver fibrosis and …
[HTML][HTML] Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver
Nonalcoholic fatty liver disease (NAFLD) is a multisystemic clinical condition that presents
with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes …
with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes …
Non-alcoholic fatty liver disease and dyslipidemia: an update
N Katsiki, DP Mikhailidis, CS Mantzoros - Metabolism, 2016 - Elsevier
Non-alcoholic fatty liver (NAFLD) is the most common liver disease worldwide, progressing
from simple steatosis to necroinflammation and fibrosis (leading to non-alcoholic …
from simple steatosis to necroinflammation and fibrosis (leading to non-alcoholic …
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
Background and aim Non-alcoholic fatty liver disease (NAFLD), affecting up to around 30%
of the world's adult population, causes considerable liver-related and extrahepatic morbidity …
of the world's adult population, causes considerable liver-related and extrahepatic morbidity …
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
A Lonardo, S Bellentani, CK Argo, S Ballestri… - Digestive and Liver …, 2015 - Elsevier
An improved understanding of non-alcoholic fatty liver disease epidemiology would lead to
identification of individuals at high risk of developing chronic liver disease and extra-hepatic …
identification of individuals at high risk of developing chronic liver disease and extra-hepatic …
Naringin attenuates high fat diet induced non-alcoholic fatty liver disease and gut bacterial dysbiosis in mice
H Mu, Q Zhou, R Yang, J Zeng, X Li, R Zhang… - Frontiers in …, 2020 - frontiersin.org
The incidence of non-alcoholic fatty liver disease (NAFLD) is rising annually, and emerging
evidence suggests that the gut bacteria plays a causal role in NAFLD. Naringin, a natural …
evidence suggests that the gut bacteria plays a causal role in NAFLD. Naringin, a natural …
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a common, progressive liver disease that affects
up to one-quarter of the adult population worldwide. The clinical and economic burden of …
up to one-quarter of the adult population worldwide. The clinical and economic burden of …
Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases
Cardiovascular diseases (CVDs) remain a leading cause of death worldwide. Among the
major risk factors for CVD, obesity and diabetes mellitus have received considerable …
major risk factors for CVD, obesity and diabetes mellitus have received considerable …